Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2018 April;109(2) > Minerva Medica 2018 April;109(2):103-15

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

REVIEW   

Minerva Medica 2018 April;109(2):103-15

DOI: 10.23736/S0026-4806.17.05488-X

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Residual renal and cardiovascular disease risk in conventionally-treated patients with type 2 diabetes: the potential of non-traditional biomarkers

Karima ZITOUNI 1, Mia STEYN 2, Kenneth A. EARLE 2, 3


To access the FULL TEXT of this article choose one of the two following options:

PURCHASE THE ARTICLE

You can access the full text of this article (PDF and HTML if available) for 2 days at a price of:  € 45,00.

INDIVIDUAL SUBSCRIBERS/MEMBERS LOGIN


TO SUBSCRIBE

top of page